Anti-Vaccinia Virus (Smallpox Vaccine) K2L Monoclonal Antibody (MP-K1303) (Mouse IgG)(MPYF-1022-KX1369)
The antibody customized production platform is used to screen the mouse monoclonal antibodies with at least 5 synthetic peptides of Vaccinia Virus (Smallpox Vaccine) K2L. The mAb with highest affinity will be selected. The selected antibody recognizes Vaccinia Virus (Smallpox Vaccine) K2L. The isotype is Mouse IgG. It can be used in applications: WB (Other applications need to be tested.).
Product Description
Species Reactivity
Vaccinia Virus (Smallpox Vaccine)
Specificity
This antibody recognizes Vaccinia Virus (Smallpox Vaccine) K2L.
Antibody Isotype
Mouse IgG
Clonality
Monoclonal Antibody
Purification
Purified by Protein A/G chromatography.
Applications
WB (Other applications need to be tested.)
Storage
Store at 4°C for short term (1 week), store at -20°C to -80°C for long term (1 year). Avoid repeated freeze-thaw cycles.
Target
Introduction
The VACV virus is a large, intricate, and enveloped member of the poxvirus family. The linear, double-stranded DNA genome of this organism is around 190 kbp long and encodes about 250 genes. The virion has dimensions of roughly 360 270 250 nm and a mass of roughly 5-10 fg. The binding of virions to and entry into a cell that is susceptible to VACV marks the start of the virus's reproduction. Nevertheless, virus entrance is regarded as occurring after the synthesis and structure of these virions have been defined because there are two structurally distinct kinds of virus, IMV and EEV.
Alternative Names
K2L; temporal expression: early; VACWR033
Official Symbol
Temporal Expression: Early
Datasheet